Search Results - "Mattarollo, Stephen R."

Refine Results
  1. 1

    Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors by MATTAROLLO, Stephen R, LOI, Sherene, DURET, Helene, MA, Yuting, ZITVOGEL, Laurence, SMYTH, Mark J

    Published in Cancer research (Chicago, Ill.) (15-07-2011)
    “…We show, in a series of established experimental breast adenocarcinomas and fibrosarcomas induced by carcinogen de novo in mice, that the therapeutic efficacy…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The prognostic significance of circulating tumor cells in head and neck and non‐small‐cell lung cancer by Kulasinghe, Arutha, Kapeleris, Joanna, Kimberley, Rebecca, Mattarollo, Stephen R., Thompson, Erik W., Thiery, Jean‐Paul, Kenny, Liz, O’Byrne, Ken, Punyadeera, Chamindie

    Published in Cancer medicine (Malden, MA) (01-12-2018)
    “…Tumor biopsy is the gold standard for the assessment of clinical biomarkers for treatment. However, tumors change dynamically in response to therapy, and there…”
    Get full text
    Journal Article
  4. 4

    Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies by Lam, Pui Yeng, Nissen, Michael D, Mattarollo, Stephen R

    Published in Frontiers in immunology (23-10-2017)
    “…Invariant natural killer T (iNKT) cells are a unique innate T lymphocyte population that possess cytolytic properties and profound immunoregulatory activities…”
    Get full text
    Journal Article
  5. 5

    Regulation of immune responses to HPVinfection and during HPV-directed immunotherapy by Bhat, Purnima, Mattarollo, Stephen R., Gosmann, Christina, Frazer, Ian H., Leggatt, Graham R.

    Published in Immunological reviews (01-01-2011)
    “…The recent development of vaccines prophylactic against human papillomavirus (HPV) infection has the potential to reduce the incidence of cervical cancer…”
    Get full text
    Journal Article
  6. 6

    NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma by Mattarollo, Stephen R., West, Alison C., Steegh, Kim, Duret, Helene, Paget, Christophe, Martin, Ben, Matthews, Geoffrey M., Shortt, Jake, Chesi, Marta, Bergsagel, P. Leif, Bots, Michael, Zuber, Johannes, Lowe, Scott W., Johnstone, Ricky W., Smyth, Mark J.

    Published in Blood (11-10-2012)
    “…Immunomodulators are effective in controlling hematologic malignancy by initiating or reactivating host antitumor immunity to otherwise poorly immunogenic and…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Langerhans cell homeostasis and activation is altered in hyperplastic human papillomavirus type 16 E7 expressing epidermis by Abd Warif, Nor Malia, Stoitzner, Patrizia, Leggatt, Graham R, Mattarollo, Stephen R, Frazer, Ian H, Hibma, Merilyn H

    Published in PloS one (18-05-2015)
    “…It has previously been shown that expression of human papillomavirus type 16 (HPV) E7 in epidermis causes hyperplasia and chronic inflammation, characteristics…”
    Get full text
    Journal Article
  9. 9

    Recruitment of Antigen Presenting Cells to Skin Draining Lymph Node From HPV16E7-Expressing Skin Requires E7-Rb Interaction by Kuo, Paula, Teoh, Siok Min, Tuong, Zewen K, Leggatt, Graham R, Mattarollo, Stephen R, Frazer, Ian H

    Published in Frontiers in immunology (18-12-2018)
    “…"High-risk" human papillomaviruses (HPV) infect keratinocytes of squamous epithelia. The HPV16E7 protein induces epithelial hyperplasia by binding Rb family…”
    Get full text
    Journal Article
  10. 10

    Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytes by Choyce, Allison, Yong, Michelle, Narayan, Sharmal, Mattarollo, Stephen R, Liem, Amy, Lambert, Paul F, Frazer, Ian H, Leggatt, Graham R

    Published in PloS one (26-02-2013)
    “…Established cancers are frequently associated with a lymphocytic infiltrate that fails to clear the tumour mass. In contrast, the importance of recruited…”
    Get full text
    Journal Article
  11. 11

    Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia by Kerage, Daniel, Soon, Megan S. F., Doff, Brianna L., Kobayashi, Takumi, Nissen, Michael D., Lam, Pui Yeng, Leggatt, Graham R., Mattarollo, Stephen R.

    Published in Oncoimmunology (03-10-2018)
    “…Immunomodulatory therapies can effectively control haematological malignancies. Previously we reported the effectiveness of combination immunotherapies that…”
    Get full text
    Journal Article
  12. 12

    B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity by McKee, Sara J., Tuong, Zewen K., Kobayashi, Takumi, Doff, Brianna L., Soon, Megan SF, Nissen, Michael, Lam, Pui Yeng, Keane, Colm, Vari, Frank, Moi, Davide, Mazzieri, Roberta, Leggatt, Graham, Gandhi, Maher K., Mattarollo, Stephen R.

    Published in Oncoimmunology (01-02-2018)
    “…Monocytosis is considered a poor prognostic factor for many cancers, including B cell lymphomas. The mechanisms by which different monocyte subsets support the…”
    Get full text
    Journal Article
  13. 13

    Natural killer cell metabolism by Kobayashi, Takumi, Mattarollo, Stephen R.

    Published in Molecular immunology (01-11-2019)
    “…•Different activation stimuli cause metabolic alterations in NK cells.•mTOR pathway activation is a key regulator of NK cell function.•NK cell dysfunction in…”
    Get full text
    Journal Article
  14. 14

    Interaction of neurotransmitters and neurochemicals with lymphocytes by Kerage, Daniel, Sloan, Erica K., Mattarollo, Stephen R., McCombe, Pamela A.

    Published in Journal of neuroimmunology (15-07-2019)
    “…Neurotransmitters and neurochemicals can act on lymphocytes by binding to receptors expressed by lymphocytes. This review describes lymphocyte expression of…”
    Get full text
    Journal Article
  15. 15

    Chemotherapy pretreatment sensitizes solid tumor‐derived cell lines to Vα24+ NKT cell‐mediated cytotoxicity by Mattarollo, Stephen R., Kenna, Tony, Nieda, Mie, Nicol, Andrew J.

    Published in International journal of cancer (01-10-2006)
    “…There is an increasing awareness of the therapeutic potential for combining immune‐based therapies with chemotherapy in the treatment of malignant diseases,…”
    Get full text
    Journal Article
  16. 16
  17. 17

    β-Adrenergic Signaling Impairs Antitumor CD8 + T-cell Responses to B-cell Lymphoma Immunotherapy by Nissen, Michael D, Sloan, Erica K, Mattarollo, Stephen R

    Published in Cancer immunology research (01-01-2018)
    “…β-Adrenergic receptor (βAR) signaling regulates many physiological processes, including immune system responses. There is growing evidence also for βAR-induced…”
    Get more information
    Journal Article
  18. 18

    An intact immune system is required for the anticancer activities of histone deacetylase inhibitors by West, Alison C, Mattarollo, Stephen R, Shortt, Jake, Cluse, Leonie A, Christiansen, Ailsa J, Smyth, Mark J, Johnstone, Ricky W

    Published in Cancer research (Chicago, Ill.) (15-12-2013)
    “…Cell-intrinsic effects such as induction of apoptosis and/or inhibition of cell proliferation have been proposed as the major antitumor responses to histone…”
    Get full text
    Journal Article
  19. 19

    IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia by Gosmann, Christina, Mattarollo, Stephen R, Bridge, Jennifer A, Frazer, Ian H, Blumenthal, Antje

    Published in The Journal of immunology (1950) (01-09-2014)
    “…Persistent infection with high-risk human papillomaviruses (HPV) causes epithelial hyperplasia that can progress to cancer and is thought to depend on…”
    Get full text
    Journal Article
  20. 20

    IL-18, but Not IL-12, Induces Production of IFN-γ in the Immunosuppressive Environment of HPV16 E7 Transgenic Hyperplastic Skin by Gosmann, Christina, Frazer, Ian H., Mattarollo, Stephen R., Blumenthal, Antje

    Published in Journal of investigative dermatology (01-10-2014)
    “…IFN-γ has a central role in the defense against infections and cancer. More recently, however, IFN-γ has also been reported to have immunosuppressive effects…”
    Get full text
    Journal Article